Prapela will commercialise medical devices for infants administering to fight drug withdrawal and cardiorespiratory problems.

Ascentage Pharma, based on research at University of Michigan, has filed to list in Hong Kong having raised about $235m in funding.

Queensland crop breeding spinout Nexgen Plants has been backed by multi-university venture fund Uniseed, Business Development Fund and Yuuwa Capital.

IP Group has joined forces with tech transfer company Crossword Cybersecurity to target the launch of more cybersecurity spinouts.

Clive Rowland will finish his tenure as CEO of the university’s commercialisation arm in the new year to take a part-time position dedicated to matters of intellectual property.

Principia Biopharma, whose drug discovery platform is based on research at UCSF, has filed for an $86.3m initial public offering having raised $50m earlier this month.

University of Twente’s ETC Solar has made its public debut as a subsidiary of a US-based Caltech spinout of the same name working on solar generation technology.

Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.